These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26639162)

  • 1. Statins and atherosclerosis: the role of epigenetics.
    Storino Farina M; Rojano Rada J; Molina Garrido A; Martínez X; Pulgar A; Paniagua R; Garrido J
    Medwave; 2015 Nov; 15(10):e6324. PubMed ID: 26639162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Control-Theoretic Model of Atherosclerosis.
    Formanowicz D; Krawczyk JB; Perek B; Formanowicz P
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review.
    Kouhpeikar H; Delbari Z; Sathyapalan T; Simental-Mendía LE; Jamialahmadi T; Sahebkar A
    Curr Atheroscler Rep; 2020 May; 22(5):19. PubMed ID: 32458165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):45-52. PubMed ID: 24038016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.
    Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH
    Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins.
    Zhao L; Ma D; Wang L; Su X; Feng L; Zhu L; Chen Y; Hao Y; Wang X; Feng J
    Front Immunol; 2023; 14():1301051. PubMed ID: 38143759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Koh KK
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2880-1. PubMed ID: 24794122
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms.
    Liberale L; Carbone F; Montecucco F; Sahebkar A
    Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.
    Cai A; Zhou Y; Li L
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124206
    [No Abstract]   [Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis.
    Blum A
    Biofactors; 2014; 40(3):295-302. PubMed ID: 25077301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
    Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
    Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of EphA2 protects against atherosclerosis by synergizing with statins to mitigate macrophage inflammation.
    Zeng J; Wu Q; Xiong S; Lu C; Zhang Z; Huang H; Xiong Y; Luo T
    Biomed Pharmacother; 2023 Dec; 169():115885. PubMed ID: 37984301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Tawakol A; Emami H; Farkouh M; Fayad ZA; Fifer K; Rudd JH; Subramanian S; Van Dyke T
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2881. PubMed ID: 24794123
    [No Abstract]   [Full Text] [Related]  

  • 16. TRPV1: a useful therapeutic target for patients with vulnerable coronary plaques.
    Li YB; Huang CX
    Med Hypotheses; 2011 Sep; 77(3):453-5. PubMed ID: 21733634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis.
    Tsilimigras DI; Bibli SI; Siasos G; Oikonomou E; Perrea DN; Filis K; Tousoulis D; Sigala F
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and the coronary plaque calcium "paradox": Insights from non-invasive and invasive imaging.
    Ferencik M; Chatzizisis YS
    Atherosclerosis; 2015 Aug; 241(2):783-5. PubMed ID: 26070488
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
    Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
    Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.